Learn More
CD66c Mouse anti-Human, Brilliant Violet 786, Clone: B6.2/CD66, BD Optibuild™
Mouse Monoclonal Antibody
Marca: BD Biosciences 742688
530.71 EUR hasta el 2025-12-31
Use el código promocional "25339" para aplicar la oferta.
Descripción
The B6.2 monoclonal antibody reacts with a glycosylphosphatidylinositol-anchored glycoprotein present on granulocytes. Antibody B6.2 was studied as recognizing CD66c in the VI Human Leukocyte Differentiation Antigen workshop. CD66 antigens also known as the carcinoembryonic antigen (CEA) family of molecules, are closely related to the immunoglobulin super family of glycoproteins. Studies on CD66 molecules suggest a potential adhesion function in vivo. These molecules exhibit both homophilic and heterophilic adhesion. CEA family members may be involved in transmembrane signalling and activation of neutrophils. This clone has been found to be N-terminal domain reactive, reacted preferentially with the native protein and were conformationally dependent
The antibody was conjugated to BD Horizon™ BV786 which is part of the BD Horizon Brilliant™ Violet family of dyes. This dye is a tandem fluorochrome of BD Horizon BV421 with an Ex Max of 405nm and an acceptor dye with an Em Max at 786nm. BD Horizon BV786 can be excited by the violet laser and detected in a filter used to detect Cy™7-like dyes (eg, 780/60nm filter). BV786 is a tandem fluorochrome of BD Horizon BV421 and an acceptor dye with an emission maximum at 786 nm. BV786 offers a bright choice for the 6th detector off the violet laser.
Especificaciones
CD66c | |
B6.2/CD66 | |
Brilliant Violet 786 | |
CEACAM6, Carcinoembryonic antigen-related cell adhesion molecule 6, NCA | |
Human Breast Carcinoma Extracts | |
50 μg | |
Primary | |
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
Monoclonal | |
0.2mg/mL | |
Aqueous buffered solution containing ≤0.09% sodium azide. | |
Mouse | |
Affinity Purified | |
RUO | |
Human | |
IgG1 κ |
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.